The FDA announced plans to hire more than 1,000 staffers and rolled out a pilot communications program to let sponsors email quick clarification questions to Office of New Drugs staff with responses promised within three business days. The agency said the new positions target reviewers, inspectors and other mission‑critical roles to accelerate drug reviews. Commissioner Marty Makary framed the changes as a way to reduce time wasted on regulatory uncertainty; the moves come amid earlier workforce cuts and criticism over missed deadlines and canceled meetings. The staffing and communications changes aim to restore predictability for sponsors.